Salivary progesterone and estriol among pregnant women treated with 17-α-hydroxyprogesterone caproate or placebo (original) (raw)
Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery
Andrew Shennan
BJOG: An International Journal of Obstetrics & Gynaecology, 2009
View PDFchevron_right
Role of Salivary Estriol to Progesterone Ratio in Prediction of Preterm Labour
Richa Yadav
International Journal of Medical Science And Diagnosis Research, 2019
View PDFchevron_right
Study of changes in levels of salivary estriol and progesterone in preterm labor in comparison to normal pregnancy
Richa Yadav
International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2019
View PDFchevron_right
Rationale & design of the PROMISES study: a prospective assessment and validation study of salivary progesterone as a test for preterm birth in pregnant women from rural India
Pankhuri Sharma, Mohan Ghule
Reproductive Health, 2018
View PDFchevron_right
Salivary progesterone and cervical length measurement as predictors of spontaneous preterm birth
Ahmed Maged
View PDFchevron_right
Predictors of Response to 17-alpha hydroxyprogesterone caproate for Prevention of Recurrent Spontaneous Preterm Birth
John Ilekis
American journal of obstetrics and gynecology, 2015
View PDFchevron_right
Impact of prior gestational age at preterm delivery on effectiveness of 17-alpha-hydroxyprogesterone caproate in practice
Victor Hugo Gonzalez-Quintero, MPH, MD
American Journal of Obstetrics and Gynecology, 2010
View PDFchevron_right
Progesterone for prevention of recurrent preterm birth: Impact of gestational age at prior delivery
Jay Iams
American Journal of Obstetrics and Gynecology, 2004
View PDFchevron_right
The Salivary Estriol Level was Higher in Preterm Delivery Compared to that in Preterm Pregnancy
erwin hermanda purba
Indonesian Journal of Obstetrics and Gynecology, 2012
View PDFchevron_right
Role of 17 α Hydroxy Progesterone Caproate (17OHPC) in the Prevention of Preterm Labor
Asma Nigar
The Journal of Obstetrics and Gynecology of India, 2012
View PDFchevron_right
Estimated Effect of 17 Alpha-Hydroxyprogesterone Caproate on Preterm Birth in the United States
Eve Lackritz, Mark Klebanoff
Obstetrics & Gynecology, 2005
View PDFchevron_right
Prevention of Preterm Birth in Triplets Using 17 Alpha-Hydroxyprogesterone Caproate
Margaret Harper
Obstetrics & Gynecology, 2009
View PDFchevron_right
17α-Hydroxyprogesterone Caproate for the Prevention of Adverse Neonatal Outcome in Multiple Pregnancies
Ewoud Schuit
Obstetrics & Gynecology, 2012
View PDFchevron_right
Oral Versus Vaginal Progesterone In Preterm Labor
mustafa abdelaziz
Evidence Based Women's Health Journal, 2018
View PDFchevron_right
Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation
Margaret Harper
American Journal of Obstetrics and Gynecology, 2012
View PDFchevron_right
Long-term follow-up of children exposed in-utero to progesterone treatment for prevention of preterm birth: study protocol of the AMPHIA follow-up
Cornelieke Aarnoudse-Moens
BMJ Open, 2021
View PDFchevron_right
Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate
Jay D
New England Journal of Medicine, 2003
View PDFchevron_right
Vaginal progesterone compared to intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: a systematic review and meta-analysis of randomized controlled trials
Gabriele Saccone
View PDFchevron_right
Comparison of the frequency of preterm births in patients treated with oral versus intramuscular progesterone with history of previous preterm birth
Khadija Shahzad
2021
View PDFchevron_right
Prevention of Preterm Birth Redux: Progesterone Works
Tony Wen
Journal of Community & Public Health Nursing, 2017
View PDFchevron_right
Preterm Delivery: Predictive Value of Salivary Estriol, and Alpha Feto Protien
Afrah Mohammed
Journal of Forensic Medicine, 2021
View PDFchevron_right
The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial
Osama El kady
Acta Obstetricia et Gynecologica Scandinavica, 2017
View PDFchevron_right
Vaginal progesterone vs intramuscular 17α‐hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta‐analysis of randomized controlled trials
Andrew Elimian
Ultrasound in Obstetrics & Gynecology, 2017
View PDFchevron_right
Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial
Mustafa Sakallı
Archives of Gynecology and Obstetrics, 2011
View PDFchevron_right
17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length
Vincenzo Berghella, Gary Hankins
American Journal of Obstetrics and Gynecology, 2010
View PDFchevron_right